AI assistant
Onxeo Board/Management Information 2024
1573_iss_2024-11-15_579a52a5-682e-4e73-88dd-4bb793b265fd.pdf
Board/Management Information
Open in viewerOpens in your device viewer
Meeting of the Board of Directors of Valerio Therapeutics S.A. on November 13, 2024
At its meeting of November 13, 2024, the Board of Directors of Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO), ("Valerio Therapeutics" or the "Company") decided to appoint Mr Julien Miara as CEO and Chairman of the Board of Valerio Therapeutics, succeeding Ms Shefali Argawal, effective immediately.
Future evolutions related to the Company's governance will be announced at a later date.
CONTACTS
Valerio Therapeutics Investor Relations [email protected] France: +33 (0) 1 70 38 33 99 U.S.: +1 617 366 1022